Affinity Asset Advisors, LLC Portfolio Holdings

Affinity Asset Advisors, LLC

  • $596 Million
  • Q2 2025

Affinity Asset Advisors, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $596 Million distributed in 91 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $57.7M, Insmed Inc with a value of $47.8M, Xenon Pharmaceuticals Inc. with a value of $34.4M, Arcellx, Inc. with a value of $32.6M, and Blueprint Medicines Corp with a value of $32M.

Examining the 13F form we can see an decrease of $300M in the current position value, from $896M to 596M.

Affinity Asset Advisors, LLC is based out at New York, NY

Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $596 Million
Healthcare: $596 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$6.47B
$57.7 Million 9.68% of portfolio
610,000
Q2 2025 Reduced 0.81%
$19.7B
$47.8 Million 8.02% of portfolio
475,000
Q2 2025 Added 239.29%
$2.45B
$34.4 Million 5.78% of portfolio
1,100,000
Q2 2025 Reduced 17.18%
$3.06B
$32.6 Million 5.47% of portfolio
495,000
Q2 2025 Reduced 6.6%
$7.73B
$32 Million 5.38% of portfolio
250,000
Q2 2025 New
$3.3B
$31.7 Million 5.31% of portfolio
415,000
Q2 2025 Reduced 9.78%
$4.83B
$28.6 Million 4.8% of portfolio
1,000,000
Q1 2025 Reduced 9.09%
$2.89B
$24.3 Million 4.08% of portfolio
440,000
Q2 2025 Added 10.0%
$7.46B
$24.2 Million 4.06% of portfolio
80,000
Q1 2025 Reduced 3.03%
$20.8B
$23.5 Million 3.94% of portfolio
1,400,000
Q3 2024 Reduced 3.45%
$1.16B
$14.4 Million 2.41% of portfolio
970,000
Q2 2025 Reduced 9.35%
$979M
$14.3 Million 2.4% of portfolio
334,863
Q2 2025 Added 19.59%
$426M
$13.9 Million 2.33% of portfolio
2,534,058
Q2 2025 Added 102.72%
$681M
$13 Million 2.18% of portfolio
2,000,308
Q2 2025 Added 9.61%
$611M
$12.8 Million 2.15% of portfolio
545,000
Q2 2025 Added 53.46%
$1.63B
$11.8 Million 1.98% of portfolio
900,162
Q2 2025 Reduced 41.8%
$276M
$9.81 Million 1.65% of portfolio
2,200,000
Q2 2025 Added 29.41%
$139M
$9.71 Million 1.63% of portfolio
4,536,182
Q2 2025 New
$161M
$7.14 Million 1.2% of portfolio
3,499,512
Q2 2025 Added 6.55%
$570M
$7.1 Million 1.19% of portfolio
1,950,000
Q2 2025 Added 30.0%
$161M
$7 Million 1.17% of portfolio
1,749,359
Q2 2025 Reduced 54.77%
$137M
$6.94 Million 1.16% of portfolio
3,045,000
Q1 2025 Reduced 32.33%
$7.41B
$6.48 Million 1.09% of portfolio
150,000
Q2 2025 Reduced 50.0%
$109M
$6.17 Million 1.03% of portfolio
1,500,000
Q1 2025 Added 200.0%
$761M
$5.45 Million 0.91% of portfolio
390,000
Q1 2025 Added 144.34%
$5.29B
$5.22 Million 0.88% of portfolio
50,000
Q2 2025 Reduced 50.0%
$195M
$5.19 Million 0.87% of portfolio
4,085,787
Q2 2025 Added 22.27%
$8.73B
$4.51 Million 0.76% of portfolio
400,000
Q2 2025 Added 166.67%
$1.79B
$4.38 Million 0.73% of portfolio
152,252
Q1 2025 Reduced 66.9%
$1.87B
$4.06 Million 0.68% of portfolio
125,000
Q2 2025 Added 400.0%
$3.04B
$3.68 Million 0.62% of portfolio
70,000
Q2 2025 Reduced 78.26%
$8.13B
$2.65 Million 0.45% of portfolio
25,000
Q2 2025 New
$555M
$2.12 Million 0.35% of portfolio
1,500,000
Q1 2025 Reduced 33.33%
$217M
$2.01 Million 0.34% of portfolio
370,000
Q1 2025 New
$342M
$1.99 Million 0.33% of portfolio
263,817
Q2 2024 Added 2.02%
$795M
$1.88 Million 0.32% of portfolio
135,000
Q2 2025 Reduced 66.25%
$98.7M
$1.61 Million 0.27% of portfolio
300,000
Q2 2025 New
$102M
$1.33 Million 0.22% of portfolio
800,000
Q4 2024 Added 23.08%
$2.73B
$1.26 Million 0.21% of portfolio
24,692
Q2 2025 Reduced 50.31%
$375M
$1.14 Million 0.19% of portfolio
500,000
Q2 2025 New
$226M
$1.07 Million 0.18% of portfolio
250,000
Q2 2025 Reduced 23.08%
$135M
$1.06 Million 0.18% of portfolio
2,302,598
Q3 2024 Added 36.41%
$49.6M
$534,000 0.09% of portfolio
752,722
Q1 2025 New
$143M
$462,000 0.08% of portfolio
200,000
Q2 2025 New
$13.1M
$341,000 0.06% of portfolio
518,025
Q2 2025 Reduced 21.58%
$71.3M
$278,000 0.05% of portfolio
200,000
Q1 2025 Added 100.0%
$88M
$220,000 0.04% of portfolio
667,516
Q1 2025 New
Karyopharm Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 24.49%
Lexeo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 142.38%

Summary

  • Portfolio
  • No. of Stocks 91
  • Current Value $596 Million
  • Prior Value $896 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 12 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email